Colony »

Lantern Pharma shares owned by Colony

Quarter-by-quarter ownership of Lantern Pharma (LTRN) shares owned by Colony from 13F filings

Historical chart of Colony investment in Lantern Pharma

Tip: Access up to 7 years of quarterly data

All positions including Lantern Pharma held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantern Pharma by Colony

Quarter filed Position value Share count Share price at filing
2025-12-31 $48k 16k 3.03

More positions owned by Colony

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr State Street Tec (XLK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Valued Advisers Tr Kovitz Core Eqt (EQTY)
Vanguard World Inf Tech Etf (VGT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Colony

Top funds holding Lantern Pharma

BIOS Capital Management
Vanguard Group
CM Management
Renaissance Technologies
Geode Capital Management
Voss Capital
BlackRock
Dimensional Fund Advisors
Goss Wealth Management
Westside Investment Management
Susquehanna International
Horizon Kinetics Asset Management
Bank of New York Mellon
Davenport & Co
State Street Corporation

View all funds holding Lantern Pharma